Literature DB >> 17401567

Prostaglandin E2 receptors EP1 and EP4 are up-regulated in rabbit chondrocytes by IL-1beta, but not by TNFalpha.

M Angeles Alvarez-Soria1, Raquel Largo, Olga Sanchez-Pernaute, Emilio Calvo, Jesús Egido, Gabriel Herrero-Beaumont.   

Abstract

Prostaglandin E2 (PGE2) exerts its actions through the binding of the high affinity EP receptors. We wanted to evaluate the regulation of EP1 and EP4, and the expression of cyclooxygenase (COX)-2, main enzyme responsible for PGE2 synthesis in inflammatory situations, in healthy rabbit chondrocytes stimulated with inflammatory mediators locally increased during osteoarthritis. Articular chondrocytes obtained from healthy rabbits were stimulated with interleukin (IL)-1beta (0.1-100 u/ml) or tumour necrosis factor (TNF)alpha (100 ng/ml). Where indicated, cells were preincubated with non-steroidal antiinflammatory drugs (NSAIDs) (10(-6) M) to inhibit PGE2 synthesis. IL-1beta induced a dose and time-dependent increase in EP1, EP4 and COX-2 expression. However, TNFalpha presence did not induce a significant modification in EP1, EP4 or COX-2 gene expression at any time of study. NSAID presence significantly inhibited PGE2 release but did not modify the EP receptors or COX-2 expression induced by IL-1beta. Our results indicate that EP1 and EP4 receptors, and COX-2 are up-regulated in IL-1beta-stimulated chondrocytes, while no significant modifications are observed in TNFalpha-stimulated cells. NSAIDs were unable to modify the expression of these mediators induced by IL-1beta. Therefore, the increase in PGE2 synthesis, induced by IL-1beta, does not seem to mediate the increase in EP receptor expression, in rabbit chondrocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401567     DOI: 10.1007/s00296-007-0328-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  32 in total

1.  High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis.

Authors:  E Calvo; I Palacios; E Delgado; J Ruiz-Cabello; P Hernández; O Sánchez-Pernaute; J Egido; G Herrero-Beaumont
Journal:  Osteoarthritis Cartilage       Date:  2001-07       Impact factor: 6.576

2.  Characterization of PGE(2) receptors (EP) and their role as mediators of 1alpha,25-(OH)(2)D(3) effects on growth zone chondrocytes.

Authors:  V L Sylvia; F Del Toro; R R Hardin; D D Dean; B D Boyan; Z Schwartz
Journal:  J Steroid Biochem Mol Biol       Date:  2001-09       Impact factor: 4.292

Review 3.  Dual acting anti-inflammatory drugs: a reappraisal.

Authors:  A Bertolini; A Ottani; M Sandrini
Journal:  Pharmacol Res       Date:  2001-12       Impact factor: 7.658

4.  Susceptibility to physiological concentrations of IL-1beta varies in cartilage at different anatomical locations on human osteoarthritic knee joints.

Authors:  A F Barakat; C J Elson; C I Westacott
Journal:  Osteoarthritis Cartilage       Date:  2002-04       Impact factor: 6.576

5.  Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells.

Authors:  Y Guan; M Chang; W Cho; Y Zhang; R Redha; L Davis; S Chang; R N DuBois; C M Hao; M Breyer
Journal:  Am J Physiol       Date:  1997-07

Review 6.  Cytokines in cartilage injury and repair.

Authors:  M Lotz
Journal:  Clin Orthop Relat Res       Date:  2001-10       Impact factor: 4.176

7.  Sequential changes of parathyroid hormone related protein (PTHrP) in articular cartilage during progression of inflammatory and degenerative arthritis.

Authors:  E Gómez-Barrena; O Sánchez-Pernaute; R Largo; E Calvo; P Esbrit; G Herrero-Beaumont
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

8.  Tumor necrosis factor-alpha upregulates the prostaglandin E2 EP1 receptor subtype and the cyclooxygenase-2 isoform in cultured amnion WISH cells.

Authors:  E P Spaziani; R R Benoit; J C Tsibris; S F Gould; W F O'Brien
Journal:  J Interferon Cytokine Res       Date:  1998-12       Impact factor: 2.607

9.  EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts.

Authors:  R Largo; I Díez-Ortego; O Sanchez-Pernaute; M J López-Armada; M A Alvarez-Soria; J Egido; G Herrero-Beaumont
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

10.  Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta.

Authors:  M P Vincenti; C E Brinckerhoff
Journal:  Arthritis Res       Date:  2001-09-18
View more
  5 in total

1.  Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition.

Authors:  Govindaiah Vinukonda; Anna Csiszar; Furong Hu; Krishna Dummula; Nishi Kant Pandey; Muhammad T Zia; Nicholas R Ferreri; Zoltan Ungvari; Edmund F LaGamma; Praveen Ballabh
Journal:  Brain       Date:  2010-05-20       Impact factor: 13.501

2.  Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E₂ release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes.

Authors:  S Meini; P Cucchi; L Tinti; S Niccolini; F Bellucci; C Catalani; C Valenti; M Galeazzi; A Fioravanti; C A Maggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-26       Impact factor: 3.000

3.  Bradykinin and B₂ receptor antagonism in rat and human articular chondrocytes.

Authors:  S Meini; P Cucchi; C Catalani; F Bellucci; S Giuliani; C A Maggi
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

4.  A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study.

Authors:  Kayo Masuko; Minako Murata; Naoya Suematsu; Kazuki Okamoto; Kazuo Yudoh; Hiroyuki Shimizu; Moroe Beppu; Hiroshi Nakamura; Tomohiro Kato
Journal:  Open Access Rheumatol       Date:  2009-04-17

Review 5.  Lipid Metabolism in Cartilage Development, Degeneration, and Regeneration.

Authors:  Zhanpeng Su; Zhixian Zong; Jinxia Deng; Jianping Huang; Guihua Liu; Bo Wei; Liao Cui; Gang Li; Huan Zhong; Sien Lin
Journal:  Nutrients       Date:  2022-09-25       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.